Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis.

Carrier Y, Ma HL, Ramon HE, Napierata L, Small C, O'Toole M, Young DA, Fouser LA, Nickerson-Nutter C, Collins M, Dunussi-Joannopoulos K, Medley QG.

J Invest Dermatol. 2011 Dec;131(12):2428-37. doi: 10.1038/jid.2011.234. Epub 2011 Sep 1.

2.

Tumor necrosis factor alpha blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells.

Ma HL, Napierata L, Stedman N, Benoit S, Collins M, Nickerson-Nutter C, Young DA.

Arthritis Rheum. 2010 Feb;62(2):430-40. doi: 10.1002/art.27203.

3.

Juvenile methylphenidate exposure and factors that influence incentive processing.

Brenhouse HC, Napierata L, Kussmaul L, Leussis M, Andersen SL.

Dev Neurosci. 2009;31(1-2):95-106. doi: 10.1159/000207498. Epub 2009 Apr 17.

4.

Juvenile methylphenidate modulates reward-related behaviors and cerebral blood flow by decreasing cortical D3 receptors.

Andersen SL, Napierata L, Brenhouse HC, Sonntag KC.

Eur J Neurosci. 2008 Jun;27(11):2962-72. doi: 10.1111/j.1460-9568.2008.06254.x.

PMID:
18588536
5.

IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation.

Ma HL, Liang S, Li J, Napierata L, Brown T, Benoit S, Senices M, Gill D, Dunussi-Joannopoulos K, Collins M, Nickerson-Nutter C, Fouser LA, Young DA.

J Clin Invest. 2008 Feb;118(2):597-607. doi: 10.1172/JCI33263.

Supplemental Content

Loading ...
Support Center